Related Experiment Video

Updated: Jul 10, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

The effect of flavonoid derivatives on doxorubicin transport and metabolism

Radka Václavíková1, Eliska Kondrová, Marie Ehrlichová

  • 1Group for Biotransformations, Center of Occupational Medicine, National Institute of Public Health, Srobarova 48, 100 42 Prague 10, Czech Republic.

Bioorganic & Medicinal Chemistry
|November 21, 2007
PubMed

Insights

Quercetin, a natural flavonoid, significantly reduced the formation of cardiotoxic doxorubicinol in breast cancer cells. Further research is recommended to explore quercetin

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Doxorubicin is a widely used chemotherapy drug for breast cancer.
  • A major limitation of doxorubicin therapy is its cardiotoxicity, partly due to the formation of cardiotoxic doxorubicinol.
  • Flavonoids are plant-derived compounds with potential therapeutic properties.

Purpose of the Study:

  • To investigate the impact of naturally occurring flavonoids and synthetic aurone derivatives on doxorubicinol formation.
  • To assess the effect of these compounds on doxorubicin transport in breast cancer cells.

Main Methods:

  • Treatment of breast cancer cells with quercetin and synthetic aurones.
  • Measurement of doxorubicinol formation.
  • Assessment of [14C]doxorubicin transport in resistant breast cancer cells.

Main Results:

  • Quercetin significantly inhibited the formation of cardiotoxic doxorubicinol.
  • Quercetin and aurones did not significantly alter the transport of doxorubicin in resistant breast cancer cells.

Conclusions:

  • Quercetin demonstrates potential in mitigating doxorubicin-induced cardiotoxicity by reducing doxorubicinol formation.
  • Quercetin warrants further investigation as a complementary agent to decrease doxorubicin-mediated toxicity in cancer patients.

More Related Videos

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Nonlinear Pharmacokinetics: Role of Transporters01:27

Nonlinear Pharmacokinetics: Role of Transporters

A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...